Ifp Advisors, Inc Fate Therapeutics Inc Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 3,360 shares of FATE stock, worth $4,468. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,360

Previous 3,360 -0.0%

Holding current value

$4,468

Previous $24,000 54.17%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$4.24 - $11.12 $2,344 - $6,149	-553 Reduced 14.13%	3,360 $19,000
Q4 2022 Feb 07, 2023	BUY	$9.86 - $23.83 $364 - $881	37 Added 0.95%	3,913 $44,000
Q3 2022 Nov 08, 2022	BUY	$21.04 - $36.06 $715 - $1,226	34 Added 0.88%	3,876 $43,000
Q2 2022 Sep 06, 2022	BUY	$17.78 - $42.39 $68,310 - $162,862	3,842 New	3,842 $43,000
Q2 2022 Aug 12, 2022	SELL	$17.78 - $42.39 $68,310 - $162,862	-3,842 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$29.67 - $60.28 $94,261 - $191,509	3,177 Added 477.74%	3,842 $148,000
Q1 2022 Aug 08, 2022	BUY	$29.67 - $60.28 $19,730 - $40,086	665 New	665 $25,000
Q3 2021 Oct 06, 2021	SELL	$59.27 - $95.73 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$67.25 - $92.52 $10,087 - $13,878	-150 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$72.16 - $117.4 $10,824 - $17,610	150 New	150 $12,000
Q4 2020 Jan 25, 2021	BUY	$38.09 - $100.95 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$30.41 - $40.5 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$20.21 - $35.23 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$17.28 - $31.88 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	SELL	$13.39 - $20.73 $267 - $414	-20 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$15.47 - $22.5 $309 - $450	20 New	20 $0
Q1 2019 May 15, 2019	SELL	$13.15 - $18.71 $317,677 - $451,996	-24,158 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$11.48 - $16.98 $36,552 - $54,064	3,184 Added 15.18%	24,158 $309,000
Q3 2018 Oct 25, 2018	SELL	$8.75 - $16.29 $30,852 - $57,438	-3,526 Reduced 14.39%	20,974 $0
Q2 2018 Aug 07, 2018	BUY	$9.16 - $13.48 $136,484 - $200,852	14,900 Added 155.21%	24,500 $0
Q1 2018 Jun 03, 2019	SELL	$6.3 - $13.77 $38,902 - $85,029	-6,175 Reduced 39.14%	9,600 $59,000
Q1 2018 May 09, 2018	BUY	$6.3 - $13.77 $38,902 - $85,029	6,175 Added 64.32%	15,775 $0
Q4 2017 Jan 24, 2018	BUY	$3.94 - $6.64 $15,760 - $26,560	4,000 Added 71.43%	9,600 $0
Q3 2017 Oct 30, 2017	BUY	$2.6 - $4.31 $1,300 - $2,155	500 Added 9.8%	5,600 $22,000
Q2 2017 Jun 03, 2019	SELL	N/A	-300 Reduced 5.56%	5,100 $17,000
Q1 2017 Jun 03, 2019	SELL	N/A	-6,640 Reduced 55.15%	5,400 $25,000
Q4 2016 Jun 03, 2019	BUY	N/A	6,840 Added 131.54%	12,040 $30,000
Q2 2016 Jun 03, 2019	BUY	N/A	5,200	5,200 $9,000

Others Institutions Holding FATE

# of Institutions

178

Shares Held

113M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $129M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account